• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疼痛性糖尿病神经病变的管理

Management of painful diabetic neuropathy.

作者信息

Tavakoli Mitra, Malik Rayaz A

机构信息

University of Manchester and Manchester Royal Infirmary, Division of Cardiovascular Medicine, Manchester, UK.

出版信息

Expert Opin Pharmacother. 2008 Dec;9(17):2969-78. doi: 10.1517/14656560802498149.

DOI:10.1517/14656560802498149
PMID:19006473
Abstract

The commonest cause of peripheral neuropathy is diabetes and pain occurs in approximately 30% of diabetic patients with neuropathy. It is extremely distressing for the patient and poses significant difficulties in management, as no treatment to date provides total relief and the side effects of therapy limit dose titration. Understanding the pathogenesis of diabetic neuropathy may lead to the development of new treatments for preventing nerve damage. Furthermore, a better understanding of the mechanisms that modulate pain may lead to more effective relief of painful symptoms. This review provides an update on the assessment and treatment of painful diabetic neuropathy.

摘要

周围神经病变最常见的病因是糖尿病,约30%的糖尿病神经病变患者会出现疼痛。这给患者带来极大痛苦,也给治疗带来重大困难,因为迄今为止尚无治疗方法能完全缓解疼痛,且治疗的副作用限制了剂量滴定。了解糖尿病神经病变的发病机制可能会带来预防神经损伤的新治疗方法。此外,更好地理解调节疼痛的机制可能会更有效地缓解疼痛症状。本综述提供了关于疼痛性糖尿病神经病变评估和治疗的最新情况。

相似文献

1
Management of painful diabetic neuropathy.疼痛性糖尿病神经病变的管理
Expert Opin Pharmacother. 2008 Dec;9(17):2969-78. doi: 10.1517/14656560802498149.
2
Pathophysiology and treatment of painful diabetic neuropathy.疼痛性糖尿病神经病变的病理生理学与治疗
Curr Pain Headache Rep. 2008 Jun;12(3):192-7. doi: 10.1007/s11916-008-0034-1.
3
Diabetic neuropathy.糖尿病性神经病变
Foot Ankle Clin. 2006 Dec;11(4):753-74. doi: 10.1016/j.fcl.2006.06.011.
4
Treatment of painful diabetic peripheral neuropathy.疼痛性糖尿病周围神经病变的治疗
Prosthet Orthot Int. 2015 Feb;39(1):17-28. doi: 10.1177/0309364614542266.
5
Management strategies for the treatment of neuropathic pain in the elderly.老年人神经性疼痛的治疗管理策略。
Drugs Aging. 2002;19(12):929-45. doi: 10.2165/00002512-200219120-00004.
6
The pathogenesis and management of painful diabetic neuropathy: a review.疼痛性糖尿病神经病变的发病机制与管理:综述
Diabet Med. 2003 Feb;20(2):88-98. doi: 10.1046/j.1464-5491.2003.00852.x.
7
Painful diabetic peripheral neuropathy.疼痛性糖尿病周围神经病变
J Am Podiatr Med Assoc. 2007 Sep-Oct;97(5):394-401. doi: 10.7547/0970394.
8
Efficacy of α-lipoic acid in diabetic neuropathy.α-硫辛酸在糖尿病性神经病变中的疗效
Expert Opin Pharmacother. 2014 Dec;15(18):2721-31. doi: 10.1517/14656566.2014.972935. Epub 2014 Nov 10.
9
A follow-up study of painful diabetic neuropathy: physical and psychological aspects.糖尿病性疼痛性神经病变的随访研究:生理和心理方面
Tohoku J Exp Med. 1983 Dec;141(4):463-71. doi: 10.1620/tjem.141.463.
10
Diabetic neuropathies in the elderly: management update.老年糖尿病神经病变:管理更新
Geriatrics. 1990 Sep;45(9):32-6.

引用本文的文献

1
Effects of Neural Mobilization on Sensory Dysfunction and Peripheral Nerve Degeneration in Rats With Painful Diabetic Neuropathy.神经松动术对痛性糖尿病周围神经病大鼠感觉功能障碍及周围神经退变的影响。
Phys Ther. 2022 Oct 6;102(10). doi: 10.1093/ptj/pzac104.
2
New Advances on Pathophysiology of Diabetes Neuropathy and Pain Management: Potential Role of Melatonin and DPP-4 Inhibitors.糖尿病神经病变的病理生理学及疼痛管理的新进展:褪黑素和二肽基肽酶-4抑制剂的潜在作用
Front Pharmacol. 2022 Apr 12;13:864088. doi: 10.3389/fphar.2022.864088. eCollection 2022.
3
Kynurenine, Tetrahydrobiopterin, and Cytokine Inflammatory Biomarkers in Individuals Affected by Diabetic Neuropathic Pain.
糖尿病性神经病理性疼痛患者体内的犬尿氨酸、四氢生物蝶呤和细胞因子炎症生物标志物
Front Neurosci. 2020 Aug 21;14:890. doi: 10.3389/fnins.2020.00890. eCollection 2020.
4
High-Mobility Group Box 1 Protein Signaling in Painful Diabetic Neuropathy.高迁移率族蛋白 1 信号在糖尿病性神经病理性疼痛中的作用。
Int J Mol Sci. 2020 Jan 30;21(3):881. doi: 10.3390/ijms21030881.
5
Minocycline attenuates the development of diabetic neuropathy by modulating DREAM and BDNF protein expression in rat spinal cord.米诺环素通过调节大鼠脊髓中DREAM和BDNF蛋白表达来减轻糖尿病性神经病变的发展。
J Diabetes Metab Disord. 2019 May 18;18(1):181-190. doi: 10.1007/s40200-019-00411-4. eCollection 2019 Jun.
6
LncRNA NONRATT021972 Was Associated with Neuropathic Pain Scoring in Patients with Type 2 Diabetes.长链非编码RNA NONRATT021972与2型糖尿病患者的神经性疼痛评分相关。
Behav Neurol. 2017;2017:2941297. doi: 10.1155/2017/2941297. Epub 2017 Aug 8.
7
Nanoparticle-encapsulated emodin decreases diabetic neuropathic pain probably via a mechanism involving P2X3 receptor in the dorsal root ganglia.纳米囊包大黄素可能通过作用于背根神经节 P2X3 受体减轻糖尿病神经病理性疼痛。
Purinergic Signal. 2017 Dec;13(4):559-568. doi: 10.1007/s11302-017-9583-2. Epub 2017 Aug 24.
8
lncRNA NONRATT021972 siRNA Decreases Diabetic Neuropathic Pain Mediated by the P2X Receptor in Dorsal Root Ganglia.长链非编码RNA NONRATT021972小干扰RNA减轻背根神经节中P2X受体介导的糖尿病性神经病理性疼痛
Mol Neurobiol. 2017 Jan;54(1):511-523. doi: 10.1007/s12035-015-9632-1. Epub 2016 Jan 7.
9
LncRNA uc.48+ is involved in diabetic neuropathic pain mediated by the P2X3 receptor in the dorsal root ganglia.长链非编码RNA uc.48+参与背根神经节中由P2X3受体介导的糖尿病性神经病理性疼痛。
Purinergic Signal. 2016 Mar;12(1):139-48. doi: 10.1007/s11302-015-9488-x. Epub 2015 Dec 19.
10
Diabetic peripheral neuropathy: should a chaperone accompany our therapeutic approach?糖尿病周围神经病变:我们的治疗方法是否应该有一个陪伴者?
Pharmacol Rev. 2012 Oct;64(4):880-900. doi: 10.1124/pr.111.005314. Epub 2012 Aug 10.